title: Changes in haemostasis and proteins of the acute phase following cardiac surgery.
abstract: After cardiac surgery performed with extracorporeal circulation (ECC) involving heart valve prostheses (PHVS, n 12) and after a bypass of the coronary arteries by a venous graft (CABG, n 19), the authors investigated the dynamics of changes of haemostasis on the 1st, 3rd, 6th, 10th and 21st day after operation. As anti-thrombotic treatment after PHVS anticoagulants were used, after CABG thrombocyte inhibitors. On the 1st day after operation in both groups thrombocytes decline, while after the 10th day their numbers increase. From the 6th day there is in both groups a rise of fibrinogen and other proteins of the acute phase (alpha-1-antitrypsin, orosomucoid and ceruloplasmin, while there was a drop of transferrin. On the 3rd and 6th day after operation fibrinolysis activators decline (euglobulin fibrinolysis). These findings suggest an increased risk of thrombophilia during the postoperative period and are probably associated with the release of interleukin-1 after Ecc and the stress of cardiac surgery. In patients with CABG on the 1st day a major drop of thrombocytes occurs, on the 6th day an elevated fibrinogen value was recorded and on the 10th day a reduced fibrinolytic activity, as compared with patients with PHVS. These changes will be, however, associated rather with a greater development of general atherosclerosis in patients with CABG, which leads to a further alteration of haemostasis, rather than with the applied antithrombotic treatment.
authors.affiliation: Department of Clinical Haematology, First Medical Faculty, Charles University, Prague.
authors.forename: J
authors.initials: J
authors.lastname: Kvasnicka
authors.forename: Z
authors.initials: Z
authors.lastname: Krska
authors.forename: I
authors.initials: I
authors.lastname: Vacková
authors.forename: J
authors.initials: J
authors.lastname: Tosovský
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism*; D001026:Coronary Artery Bypass; D005112:Extracorporeal Circulation; D005260:Female; D006350:Heart Valve Prosthesis; D006487:Hemostasis / Q000502:physiology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000097:blood; D013312:Stress, Physiological / Q000097:blood; D013921:Thrombocytopenia / Q000209:etiology; D013922:Thrombocytosis / Q000209:etiology
chemical_list: D000209:Acute-Phase Proteins; D010975:Platelet Aggregation Inhibitors; D006493:Heparin